You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023114010
Dec 20232209
Jan 20244102
Feb 20242204
Mar 202418010
Apr 20241607
May 20243807
Jun 20241400
Jul 2024802
Aug 20242405
Sep 20241002
Oct 20241007
Nov 20241204
Dec 20241606
Jan 20253607
Feb 2025406
Mar 2025009
Apr 2025003
May 2025007
Jun 2025004
Total4050111